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Abstract Introduction The aim of this study was to
examine the health- and work outcomes of renal transplant
recipients long-term after transplantation as well as the
pattern of work status, work ability and disability beneﬁts
during the end-stage renal disease (ESRD) trajectory that
precedes transplantation. Methods 34 transplant recipients
completed interviews 3, 13 months and [6 years post-
transplantation. Health status (SF-36), work ability (WAI),
and fatigue (CIS) were assessed by questionnaires, clinical
data were derived from medical charts, and data on func-
tional limitations were extracted from the social security
system database. The work status trajectory preceding
transplantation was examined retrospectively. Results Of
the 34 third wave transplant recipients, 29% were severely
fatigued. Compared with the general working population,
recipients experienced worse general health and less
vitality. Non-working recipients had worse renal function
and general health, and more limitations in physical func-
tioning compared to working recipients. The WAI score
indicated moderate work ability for 60% of the employed
recipients. Although 67% were employed (45% parttime),
30% of those working still received some disability bene-
ﬁts. Social insurance physicians found variable levels of
functional limitations. The mean work status trajectory
showed more sickness absence and less work ability during
dialysis, but after transplantation, both work status and
work ability generally improved. Conclusions Transplant
recipients have a compromised health status which leads to
functional limitations and disability. Although work status
improved after transplantation, a substantial number of the
transplant recipients received disability beneﬁts. The neg-
ative health consequences of anti-rejection medications
may play an important role in long-term work ability.
These results indicate that a ‘new’ kidney has advantages
over dialysis with respect to work, but does not necessarily
leads to ‘normal’ work outcomes.
Keywords Renal transplantation  End-stage renal
disease  Employment  Disability  Work ability  Fatigue
Introduction
End-stage renal disease (ESRD) is a complete or near
complete failure (i.e., less than 10% of normal function) of
the kidneys. It is a permanent and irreversible condition
often featured by a slowly progressive loss of function over
a period of months or years. Renal replacement therapy
compensates the loss of renal function. Nowadays, renal
transplantation has become a routine procedure and is the
treatment of choice for ESRD, as it has a better prognosis
when compared to dialysis [1, 2]. Transplantation offers
recipients the potential for restoring a productive and
independent life [3, 4], although it does not equal complete
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regimen, prescribed to prevent allograft rejection, has
numerous side-effects that necessitate regular medical
checkups [5]. Besides weight gain, hirsutism, mood swings
and osteoporosis, patients are confronted with an increased
risk for infection, hypertension, neuropathy, cataract
and post-transplant diabetes mellitus. These comorbid
conditions may lead to functional limitations and work
disability.
Despite the burden of ESRD, a signiﬁcant number of
transplant recipients are able to return to work. A review
of studies published between 1980 and 2003 showed that
employment rates of renal transplant recipients ranged
between 18 and 82% [6]. More recent studies reported
employment rates of 25% [7], 29% [8], 49% [9, 10], 52%
[11], and 59% [12]. Comparison of these rates across the
studies is hampered by differences in deﬁning categories
of employment (e.g., including full-time students and
homemakers) and heterogeneity of study populations with
regard to demographic and clinical characteristics [6].
Most of these studies had a cross-sectional design and
some studies retrospectively collected data on work status
pretransplantation.
To our knowledge, the study of Matas et al. [13] is the
only study that examined patterns of work status prospec-
tively. They found that 22% of the transplant recipients
who received disability beneﬁts preceding transplantation
returned to full-time work (or school). Of those who
dropped out of work after transplantation, 34% reported
being work disabled. Apparently, work limitations remains
an issue after transplantation. It is the main reason for not
being employed as reported by 68% of transplant recipients
without a paid job [11].
In 2002, we started a follow-up study among renal
transplant recipients which aimed to describe changes in
social participation (i.e., work, education, household tasks,
leisure activities) in the ﬁrst year after transplantation [14].
Considering work status, we found a rather stable
employment rate during the ﬁrst year after transplantation
indicating that those who were able to maintain their job
before transplantation did return to work. A substantial
proportion of the working transplant recipients, however,
did receive additional disability beneﬁts. As little is known
about long-term work outcomes after transplantation, we
decided to perform a third follow-up wave. The aim of the
present study is to examine the long-term health- and work
outcomes of renal transplant recipients [6 years after
transplantation. In addition, the pattern of work status,
work ability and disability beneﬁts during the ESRD tra-
jectory that precedes transplantation are examined. To our
knowledge, this is the ﬁrst study that describes the work
status trajectory of ESRD patients from diagnosis to long-
term after transplantation.
Methods
Design and Study Population
The current study is a third wave (T3) in a cohort of kidney
transplant recipients (C18 years) who were transplanted at
the University Medical Centre Groningen (UMCG)
between March 1, 2002 and March 31, 2003. Patients with
a stable renal allograft function after primary kidney
transplantation were eligible. Combined transplant (i.e.,
kidney/pancreas, kidney/liver) and retransplant recipients
were excluded, as were patients unable to understand
Dutch. After receiving information during a visit at the
outpatient clinic, patients signed informed consent (base-
line wave response rate 79%). The study was approved by
the Medical Ethics Review Committee of the UMCG.
Figure 1 shows the inclusion, eligibility and follow-up
data from the cohort of transplant recipients. The baseline
data collection wave (T1) was performed at 3 months and
the second wave (T2) at 1 year posttransplantation [14].
For the third wave (March and April 2009; [6 years
posttransplantation), eligibility assessment of the T2 study
group (n = 58) showed that four recipients (7%) had died,
three recipients (5%) were back on dialysis, and two (3%)
had expressed unwillingness to participate in future studies.
Of the remaining 49 eligible recipients, 34 (69%) agreed to
participate. The results presented in this paper are based on
these 34 transplant recipients.
Nonresponders were older (mean 55.3 years; mean dif-
ference 10.7 years; 95% CI 3.4–18.1; P\0.05) but did not
differ for gender (P = 0.74). An attrition bias analysis,
comparing T3 study participants to those who were lost to
follow-up (n = 27), showed that T3 study participants had
a higher educational level (58.8% upper secondary or ter-
tiary education vs. 29.6% in the lost to follow-up group;
P = 0.02). No differences were found for the other
demographic and clinical characteristics as listed in
Table 1. With respect to the work outcomes of this study,
we found a higher work status in T3 study participants
(51.5% vs. 37.5% in the lost to follow-up group), although
not statistically signiﬁcant (P = 0.29). However, transplant
recipients who were lost to follow-up more often received
disability beneﬁts at baseline (79.2% vs. 51.5% in the T3
study group; P = 0.03).
Procedure and Measurements
Socio-Demographic and Clinical Characteristics
Age, gender and highest attained level of education [15]
were assessed at baseline (T1). Data on clinical charac-
teristics were collected at baseline and at T3 by reviewing
medical charts and the Groningen Renal Transplant
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123Database. Primary renal disease was classiﬁed according to
the ERA-EDTA [16]. Comorbidity was deﬁned as: (1)
diabetes mellitus (insulin or oral antidiabetic drugs
dependent); (2) presence of cardiac disease evidenced by a
history of cardiovascular events (i.e., previous myocardial
infarction, coronary artery bypass grafting, percutaneous
transluminal coronary angioplasty, cardiac valve replace-
ment); (3) cerebro vascular disease evidenced by a history
of previous cerebro vascular events (i.e., cerebro vascular
accident, transient ischemic attack, carotid artery bypass
grafting, percutaneous transluminal femora angioplasty,
peripheral vascular disease surgery [bypass, embolectomy,
amputation]); (4) non-cutaneous malignancy posttrans-
plantation. In addition, we collected data on type of
transplantation (cadaveric vs. living), type of dialysis
(peritoneal vs. hemodialysis) and duration of dialysis prior
to transplantation (years), renal allograft function (esti-
mated glomerular ﬁltration rate (GFR), mL/min/1.73 m
2;
calculated by using the abbreviated MDRD equation with
serum creatinine measured in mg/dL [17]), and anthropo-
metric characteristics.
Health Outcomes
Data on health outcomes were collected by a standardized
self-report questionnaire, sent to participants preceding the
T3 interview.
Health status was assessed with the Medical Outcomes
Study 36-item Short-Form Health Survey (SF-36) [18]
consisting of eight multi-item scales: physical functioning,
role limitations due to physical health problems, bodily
pain, general health perceptions, vitality, social function-
ing, role limitations due to emotional problems, and mental
health. Higher scores indicate higher levels of functioning
and health (range 0–100). In the present study the Cron-
bach’s alphas ranged from 0.69 to 0.91. SF-36 scores of
transplant recipients were compared with normative data of
Cohort primary kidney transplantation 
n=118 
Assessed for eligibility 
n=98 
Not eligible (n=16): 
  3 on dialysis due to graft loss 
  1 follow-up at other medical centre  
  1 mental retardation 
  9 inadequate mastery of Dutch 
  2 blindness  
Not assessed for eligibility (n=4) 
  4 missed invitation for informed consent procedure 
Did not provide consent (n=16): 
  16 declined to participate 
Lost after consent (n=1) 
 1 deceased
Eligible 
n=78 
Baseline (T1) data collection 
n=61 
Lost to follow-up (n=3):
  2 participation in study is too burdensome 
  1 declined further participation in study 
T2 data collection 
n=58
Lost to follow-up (n=24): 
￿ Not eligible (n=7): 
      4 deceased  
      3 on dialysis due to graft loss
￿ Did not provide consent (n=17): 
      2 expressed unwillingness to participate in future studies on T2 
      15 declined to participate 
T3 data collection 
n=34 
Excluded (n=20): 
  13 received retransplantation 
  6 received combined transplantation 
  1 deceased 
Fig. 1 Flow diagram of inclusion, eligibility and follow-up of renal transplant recipients
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123Table 1 Socio-demographic, clinical and health status characteristics of the total study group (n = 34) and stratiﬁed for work outcome in
working age patients (18–64 years; n = 30)
Total group n = 34 Employed n = 20 Non-working n = 10 P value
Age, mean (SD) 50.5 (11.5)
Range 25.0–78.5
46.2 (10.0) 51.6 (7.5) 0.14
Gender (male), n (%) 19 (55.9) 11 (55.0) 6 (60.0) 1.00
Living arrangement (with others), n (%) 31 (91.2) 19 (95.0) 8 (80.0) 0.25
Educational status, n (%) 0.43
Primary or lower secondary 14 (41.2) 6 (30.0) 5 (50.0)
Upper secondary or tertiary 20 (58.8) 14 (70.0) 5 (50.0)
Primary renal disease, n (%)
Glomerulonephritis 26 (76.5) 17 (85.0) 7 (70.0) 0.69
Renal vascular disease 1 (2.9) 1 (5.0) 0 (0)
§
Polycystic renal disease 4 (11.8) 1 (5.0) 1 (10.0)
§
Other/unkown cause 3 (8.8) 1 (5.0) 2 (20.0)
§
Comorbidity, n (%), n = 1 missing n = 1 missing
Diabetes mellitus 6 (18.2) 2 (10.5) 4 (40.0) 0.14
Insulin dependent 2 (33.3) 0 (0) 2 (50.0)
Oral antidiabetic drug 4 (66.7) 2 (100.0) 2 (50.0)
Cardiac disease 3 (9.1) 1 (5.3) 1 (10.0)
§
Cerebrovascular disease 4 (12.1) 2 (10.5) 0 (0)
§
Malignancy (non-cutaneous) 3 (9.1) 2 (10.5) 1 (10.0)
§
Type of transplantation, n (%) 0.68
Cadaveric 23 (67.6) 14 (70.0) 8 (80.0)
Living 11 (32.4) 6 (30.0) 2 (20.0)
Pre-transplant dialysis, n (%) 0.66
Hemodialysis 10 (29.4) 4 (20.0) 3 (30.0)
Peritoneal 24 (70.6) 16 (80.0) 7 (70.0)
Duration of dialysis, in years, median 3.3
Range 0.5–7.6
3.3 4.5 0.63
Time since transplantation, in years, mean (SD) 6.4 (0.3)
Range 6.0–7.1
6.5 (0.3) 6.3 (0.3) 0.11
Estimated GFR, mL/min/1.73 m
2§ 52.8 (±15.7)
Range 21.7–79.5
55.8 (12.4) 43.9 (19.1) 0.05*
BMI, kg/m
2 25.5 (4.5)
Range 18.5–36.9
24.9 (4.4) 26.8 (5.1) 0.31
BMI, n (%) *
\25 19 (55.9) 12 (60.0) 6 (60.0)
25–29 10 (29.4) 6 (30.0) 1 (10.0)
C30 5 (14.7) 2 (10.0) 3 (30.0)
Health status (SF-36)
a, mean (SD)
Physical functioning 76.8 (21.1) 84.8 (14.0) 69.0 (23.7) 0.03*
Role-physical 67.6 (41.5) 86.3 (26.3) 27.5 (38.1) \0.01**
Bodily pain 70.6 (25.2) 76.7 (22.1) 64.1 (26.5) 0.18
General health 54.1 (19.1) 60.8 (19.3) 42.9 (14.7) 0.02*
Vitality 60.0 (18.5) 60.5 (18.3) 58.5 (19.9) 0.79
Social functioning 80.1 (21.1) 86.3 (17.2) 68.8 (23.0) 0.03*
Role-emotional 73.5 (40.0) 81.7 (33.3) 56.7 (47.3) 0.16
Mental health 74.4 (15.1) 74.6 (14.7) 72.0 (18.8) 0.68
Fatigue (CIS)
b, mean (SD) 29.2 (12.9) 26.0 (12.7) 33.9 (10.9) 0.10
a Higher scores indicate higher levels of health status
b Higher scores indicate higher levels of fatigue
§ Statistical signiﬁcance not tested due to empty cells or low expected frequencies
* P B 0.05; ** P B 0.01
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123the general population (n = 1,742; mean age 47.6 (SD
18.0); 56% male; [18]).
Fatigue was assessed by the subscale ‘fatigue severity’
of the Checklist Individual Strength (CIS) questionnaire
[19] which consists of eight statements. Respondents
indicate on a seven-point scale to what extent the particular
statement applies to him or her. A higher score indicates a
higher degree of subjective fatigue (range 8–56). A score of
C35 indicates severe fatigue [20]. Although the CIS orig-
inally was developed for the assessment of chronic fatigue
syndrome this questionnaire was also validated in a
working population [21]. In the present study Cronbach’s
alpha was 0.88. The level of fatigue of transplant recipients
was compared with data on fatigue in a working population
(n = 37; mean age 35.0 [SD 6.4]; 49% male; [21]).
Work Outcomes
Data on work status and disability beneﬁts were measured
three times (i.e., T1, T2, T3) by interview at patient‘s
homes. Methodology of data collection is described in
detail elsewhere [11, 22].
Work status was measured as the number of hours
worked weekly according to contract, including self-
employed. Employment was classiﬁed as working for pay,
i.e., full-time (C30 h/week) or part-time (12–29 h/week).
According to the deﬁnition of Statistics Netherlands, per-
sons who worked less than 12 h per week were labelled as
unemployed.
Disability beneﬁt was deﬁned as receiving either a full
or partially social security beneﬁt administered under the
Work Incapacity Act (WAO) or the act on Work and
Income according to Work Capacity (WIA). Those who
received a disability pension were asked to consent to
extract their data on functional limitations from the social
security system database as ﬁlled out by social insurance
physicians after clinical examination.
Work Ability Transplant recipients in the third wave (T3)
study group who had a paid job (C12 h/week) were asked
to ﬁll out the Work Ability Index questionnaire (WAI)
[23], a summary measure of seven items (range 7–49). The
WAI score is classiﬁed into poor (7–27), moderate (28–36),
good (37–43) and excellent (44–49) work ability. WAI
scores of transplant recipients were compared with nor-
mative data from the general working population
(n = 3,000; ﬁve companies; data unpublished) and with a
population aged C45 years with a chronic disease
(n = 1,100; mean age 53.3 (SD 4.8); 44% male; [24]).
Furthermore, the work ability trajectory of all recipients
was examined retrospectively. For this purpose we used the
ﬁrst item of the WAI questionnaire, which asks patients to
estimate their work ability compared with the lifetime
best (range 0 [unable to work] to 10 [lifetime best]).
To minimize recall bias, patients were requested to esti-
mate their work ability at three distinctive time points in
the history of renal disease (i.e., diagnosis of ESRD; start
of dialysis; admission for transplantation). Three additional
aspects of work ability (i.e., physical capability, speed of
work, ability to concentrate) were assessed accordingly.
Pattern of Work Outcomes For the description of the
work outcomes during the ESRD trajectory we used the
prospective posttransplantation data (T1, T2, T3), as well
as the retrospective data on pretransplantation work out-
comes which were assessed at baseline. For this purpose
transplant recipients reported work status and disability
beneﬁts on the three distinctive time points in the history of
renal disease as mentioned above.
Statistical Analysis
Non-response analysis, attrition analysis and analysis of
differences between working and non-working study par-
ticipants were performed with the independent sample
t test, the Mann–Whitney test and Chi-squared test. The
Fisher’s Exact test was used if expected frequencies were
below ﬁve. Comparison with normative data was tested
with the independent sample t test. P value B 0.05 (two-
sided) was considered statistically signiﬁcant. Data analy-
sis was performed using SPSS, version 16.0 (SPSS, Inc.,
Chicago).
Results
Study Population
The socio-demographic and clinical characteristics of the
third wave study participants (n = 34) are outlined in
Table 1. Four recipients were aged C65 years. Six patients
(18.2%) had diabetes mellitus (DM). Five patients devel-
oped DM posttransplantation and one patient had DM
before onset of ESRD, but their ESRD was caused by
glomerulonephritis. Three recipients developed posttrans-
plantation lymphoproliferative disorder (PTLD). The mean
time since transplantation was 6.4 years (range 6.0–7.1).
Health Outcomes Long-Term After Transplantation
Data on the SF-36 (Table 1) show that scores on the sub-
scale ‘general health’ were lowest whereas scores on
‘social functioning’ were highest, indicating that transplant
recipients were least restricted in social functioning.
Comparison with normative data from the general popu-
lation [18] indicated that transplant recipients had signiﬁ-
cantly lower level of general health perceptions (mean
difference -16.5; 95% CI -23.2 to -9.9; P\0.001) and
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123vitality (mean difference -8.6; 95% CI -15.1 to -2.1;
P\0.05). Differences on the other SF-36 subscales were
not statistically signiﬁcant although the physical function-
ing difference was of borderline signiﬁcance (P = 0.09).
Application of a standard cutoff point (C35) classiﬁed
10 transplant recipients (29.4%) as being ‘severely fati-
gued’. Comparison of these results with fatigue in a
working white collar population showed that transplant
recipients had higher levels of fatigue (mean difference
8.8; 95% CI 4.4–13.3; P\0.001).
Work Outcomes Long-Term After Transplantation
Of the thirty recipients of working age (\65 years), 67%
(n = 20) were employed. Forty-ﬁve percent worked part-
time (\30 h/week) and 2 recipients were self-employed.
Median time to return to work after transplantation was
6 months (range 1–60). Of those employed, six recipients
(30%) were receiving disability beneﬁts in addition to
wages. Six recipients had a blue collar job, ﬁve had an
administrative job, six did policy work, and three recipients
had an executive job. At the time of data collection, one
transplant recipient was on sick leave due to gout. For 12
recipients, it was a ﬁnancial necessity to have a paid job as
they were breadwinners. Other reasons for having a paid
job listed were: social contact (n = 11), enjoy work
(n = 10), nice colleagues (n = 6), importance of work
(n = 6), and the opinion that one ought to work (n = 2).
Of the 10 non-working recipients, ﬁve received a disability
beneﬁt, two recipients only had a minor job (3 and 10 h,
respectively), one was early retired, one recipient was
looking for a job, and one recipient was a homemaker.
Comparison of non-working and working recipients
(Table 1) shows that non-working recipients had signiﬁ-
cantly lower renal allograft function, lower physical, role-
physical and social functioning, and worse general health.
The difference in fatigue was of borderline statistical sig-
niﬁcance (P 0.10).
Thirty-seven percent (n = 11) of the study group were
receiving some disability beneﬁts (n = 5 full; n = 6 par-
tial) at the last follow-up. The recipients who were
receiving a partial disability beneﬁt also had a paid job
(83% part-time). Five recipients (46%) reported that their
disability was caused by ESRD and four recipients (36%)
reported that disability was related to a combination of
ESRD and other chronic diseases such as systemic lupus
erythematosus (n = 2), visual impairment (n = 1) and
chronic fatigue (n = 1). Only two recipients (18%) were
disabled due to other diseases such as visual impairment
(n = 1) and chronic low back pain (n = 1). Seven disabled
recipients (64%) reported a disagreement with the social
insurance physician on their capability of weekly working
hours: three recipients who were fully disabled had the
opinion that they were able to work a maximum of 10 h per
week, whereas four recipients stated that they were not
capable to work the amount of hours as prescribed by the
social insurance physician.
Six (55%) of the disabled transplant recipients gave
informed consent to extract data on functional limitations
from the social security administration. Functional limita-
tions as assessed by the social insurance physician were
related to: special requirements for the physical work
environment (n = 5), sustained and frequent bending
(n = 4) and reaching (n = 3), pushing or pulling dynamic
(n = 3), sustained and frequent lifting or carrying (n = 4),
sustained and frequent handling of light (n = 2) and heavy
(n = 5) objects, sustained walking (n = 4) and standing
(n = 4), kneeling or squatting (n = 1), working above
shoulder level (n = 3), stair climbing (n = 2), and alter-
nating posture (n = 1). With respect to working hours,
there were limitations in working in evening (n = 2) and
night shifts (n = 2), in number of daily working hours
(n = 4; max 6 h), and number of weekly working hours
(n = 4; max 30 h).
The transplant recipients who had a paid job (n = 20)
ﬁlled out the WAI questionnaire (mean score 36.3 (SD
5.3); range 27–46). The majority of the recipients (n = 12;
60.0%) had a moderate work ability and one recipient (5%)
had a poor work ability. The percentage of workers with
good or excellent work ability was 20% and 15%,
respectively. Compared to a reference group of Dutch
employees (M = 40.6), transplant recipients had a lower
mean level of work ability (mean difference -4.4; 95% CI
-6.8 to -1.9; P\0.01). Compared to data from Dutch
employees with a chronic disease (M = 35.3), they had a
similar level of work ability (mean difference 0.95; 95% CI
-1.5 to 3.4; P = 0.43).
Pattern of Work Outcomes During the ESRD
Trajectory
Figure 2 presents the pattern of work status and disability
beneﬁts of the third wave study participants throughout the
ESRD trajectory (i.e., from the diagnosis of ESRD to long-
term follow-up after transplantation). At the time that
ESRD was diagnosed, 74% had a paid job. This proportion
remained stable during the pre-dialysis phase (72%
employed at the start of dialysis). However, 26% of those
employed were on full sick leave by then. Once dialysis
had started, more patients quit working as evidenced by the
decreased employment rate (50% employed at transplan-
tation). Moreover, 19% of those employed were on full
sick leave at transplantation. In the ﬁrst year after trans-
plantation the proportion of patients with a paid job
remained stable (53% at 1 year follow-up) but then
increased long-term (67% at 6 years follow-up).
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of work status, only in the opposite direction. The pro-
portion of patients receiving a disability beneﬁt increased
preceding transplantation (4% at diagnosis; 22% at start of
dialysis; 53% at transplantation). One year post-trans-
plantation 47% were receiving a disability beneﬁt whereas
in the long-term 37% remained disabled. With respect to
the distinction between full and partial disability beneﬁts
the results indicated a decrease in full disability post-
transplantation. Of those receiving a disability beneﬁt, 59%
were fully disabled at transplantation, 53% were fully
disabled at 1 year follow-up, and 45% were fully disabled
at 6 years follow-up, respectively. As a result, the pro-
portion of partial disability beneﬁts increased (41% at
transplantation; 47% 1 year follow-up; 55% 6 years fol-
low-up). The assignment of a disability beneﬁt was pre-
ceded by sick leave as reported in the previous paragraph
(maximum duration of sick leave during employment in the
Netherlands is 2 years).
The pattern of overall work ability of the third wave
study group during the ESRD trajectory (Fig. 3) showed a
decrease of work ability during the pre-dialysis phase
which persisted throughout dialysis, but improved after
transplantation. However, work ability long-term after
transplantation was below the level of work ability pre-
ceding diagnosis of ESRD. There was a similar pattern for
physical capability, speed of work and ability to concen-
trate. Ability to concentrate was the least affected aspect of
work ability.
Discussion
This follow-up study described the health- and work out-
comes in 34 renal transplant recipients long-term ([6 years)
after transplantation. The results showed that recipients
reported worse general health and vitality compared to the
general population which can be attributed to impaired
physical functioning. A substantial number of the recipients
were classiﬁed as severely fatigued. Non-working recipi-
ents had lower renal function, worse general health and
more limitations in physical and social functioning com-
pared to working recipients. Although work status
improved after successful kidney transplantation, more than
one third of the recipients with successful transplants still
depended on disability beneﬁts in the long-term. Of those
employed, the majority had moderate work ability. Exam-
ination of work outcomes preceding transplantation indi-
cates that renal failure causes sickness absence and leads to
disability even before dialysis has started. During dialysis
the proportion of recipients with disability beneﬁts further
increased. The results of our study demonstrated that a
‘new’ kidney does not necessarily leads to ‘normal’ work
status and good work ability, but it has signiﬁcant advan-
tages compared to dialysis in this respect.
Our results on self-reported health status showed com-
promised general health in transplant recipients compared
with the general population. Renal transplantation is
accompanied by adverse effects and various complications
[25]. Besides the increased risk for cardiovascular mor-
tality [26], the lifelong use of immunosuppressive medi-
cation introduces new health risks such as hypertension
[27], bone disorders [28], post-transplantation diabetes
[29], and an increased risk for cancer [30] and infection. In
addition, health status is affected by the side-effects of
immunosuppressive medication [31]. Transplant recipients
have to face these downsides in their day-to-day lives.
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Fig. 3 Work ability of the third wave study group during the ESRD
trajectory (n = 34)
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123The employment rate in the present study was 67%
which is higher than most of the employment rates found in
previous studies performed in other countries (range
18–82% [6–10, 12, 13, 32, 33]). It is also higher than the
employment rate we found in our cross-sectional study
(48%; minor jobs\12 h/week excluded [11]). With respect
to pretransplantation employment rates, the present study
found higher rates compared to a Dutch study in ESRD
patients that showed an employment rate of 51% in pre-
dialysis patients [34] and 24% in dialysis patients [35],
where we found 72 and 50%, respectively. These higher
rates may be explained by a better health status of our study
participants during (pre-)dialysis which is one of the eli-
gibility criteria for renal transplantation, as well as selec-
tion bias due to drop-out of older and sicker participants.
Differences in employment rates between studies may be
related to differences in social legislation between coun-
tries. The Dutch legislation is focused on participation in the
labour force and aims to prevent compensation of work loss.
In the USA, the willingness of transplant recipients to return
to work may be affected by the potential loss of disability-
related coverage for expensive immunosuppressive medi-
cation [36] which is clearly a barrier to employment [10]. In
the Dutch social legislation system there is no connection
between health insurance and disability beneﬁts, and return
to work is further encouraged by the possibility of supple-
mentary partial disability beneﬁts. This was the case in 30%
(n = 6) of the employed recipients in our study.
A substantial number of our study group remained
(partial) disabled (37%) which is in line with previous
studies. Overbeck et al. [7] found in a sample of German
renal transplant recipients that 42% were permanently out
of work due to disability. In a Belgian sample of four
different organ transplants (i.e., kidney, heart, liver, lung),
De Baere et al. [12] reported that 45% of the organ
recipients were medically unable to work or received a
disability beneﬁt.
Disability in our study group appears to be primarily
caused by physical impairment, as transplant recipients
reported impaired general health and fatigue, and a
decreased level of physical function work ability. Fatigue is
known to be related to sickness absence [37] and work
disability [38]. Likewise, poor work ability is a determinant
of receiving disability beneﬁts [39]. There is little available
information about speciﬁc functional impairments in
transplant recipients. Manninen et al. [40] reported that
transplant recipients experienced functional limitations in
reaching, reading and carrying weights. The majority of
transplant recipients experience musculoskeletal disorders
[41] which affect physical functioning [42]. For some
patients the prospect of doing certain types of work
therefore may be poor [40]. Our study participants also
experienced functional limitations according to objective
criteria (i.e., assessed by an social insurance physician)
which resulted in a disability beneﬁt. It can be assumed that
those who are not disabled and are capable of having a job
experience functional limitations as well, as we found
impaired work ability and high levels of fatigue even in
employed persons. Our results indicate that impaired work
ability is common, but also indicates a substantial variation
among transplant recipients. The relatively low point
prevalence of patients on renal replacement therapy in the
Netherlands (n = 14.690 [43]) and the consequently small
number of these patients in social insurance physician’s
practices, may imply a lack of expertise. Together with the
wide inter-rater variability between physicians in assessing
disability [44] it is not surprising that we found a dis-
crepancy in opinions between social insurance physicians
and patients with respect to the capability of weekly
working hours. A previous Dutch study found signiﬁcant
differences between self-reported work limitations and
limitations as reported by social insurance physicians [45].
Hopefully, the recently developed practice guideline for
social insurance physicians [46], which was developed in
close cooperation with clinicians, social insurance physi-
cians, occupational physicians, labour experts and a health
scientist, may assist social insurance physicians in correctly
assigning disability beneﬁts to ESRD patients.
With respect to the pattern of work outcomes our study
showed a substantial loss of work during the pre-dialysis
phase as well as during dialysis. Obviously, the decline in
renal function is accompanied by a decline in physical and
functional capacity [47] resulting in an impaired work
ability [48] and sickness absence. Dialysis, which is an
invasive and time consuming treatment, further deteriorates
ability to participate in work [12, 49], which improves after
transplantation. Several studies point out that pretransplant
work status is an important determinant of work status
posttransplantation [8, 12, 13, 32, 33]. Vocational rehabili-
tation, which should have a multidisciplinaryapproach [50],
may help ESRD patients to maintain their work [51, 52].
The examination of work outcomes throughout the
ESRD trajectory, the long-term follow-up after transplan-
tation, and the data collection at relatively the same length
of time after transplantation in each study participant are
strengths of the present study. In addition, our study was
able to obtain data on functional limitation ratings from the
social security system database. However, there are some
shortcomings. The relatively small third wave study group
represents a selective sample from the cohort of patients
that were transplanted in 2002 and 2003. Study participants
had a higher educational level and less often received
disability beneﬁts at baseline compared to those who were
lost to follow-up. This may have resulted in a higher work
status and less disability beneﬁts. Therefore, our study
probably overestimates work status and underestimates
332 J Occup Rehabil (2011) 21:325–334
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Moreover, it is not clear if our study group is representative
for patients transplanted at other centres in the Netherlands.
Therefore, this study should be regarded as a pilot study
that triggers the development of larger studies. Lastly, the
retrospective part of the baseline interview that requested
patients to recall their work status as well as the retro-
spective assessment of work ability may have introduced
recall bias. Despite these limitations our study contributes
to the understanding of the pattern of work status in renal
transplant recipients.
Our study demonstrated that patients during their ESRD
‘career’ are confronted with decreased work ability, sick-
ness absence and work disability. However, there are also
good prospects for maintaining work during this trajectory,
and return to sustainable work after transplantation. These
transitions may require adaptation not only by patients but
also by their work and living environments. Because of the
complexity of problems and limitations ESRD patients
experience, vocational rehabilitation, preferably with a
multidisciplinary approach, may be helpful [53]. Job
retention during (pre-)dialysis should be one of the aims of
these interventions, because it is easier to return to work
after a period of sick leave caused by the transplantation,
than to ﬁnd a new job. Patients should remain actively
employed as long as possible before transplantation [12].
However, for many patients, maintaining employment
during (pre-)dialysis is only feasible with signiﬁcant work
modiﬁcations, such as the reduction of working hours and
work tasks, and sufﬁcient control over the working situa-
tion, in order to ﬁt in treatment with working life. Inter-
ventions based on empowerment and self-management of
ESRD patients may be worthwhile [51, 54, 55]. Nephrol-
ogy professionals have a key role in the assessment of
work-related problems. They should not only pay more
attention to this issue but also cooperate and communicate
with vocational rehabilitation specialists [46].
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